WO2004111088A3 - Angiogenic factor and inhibitors thereof - Google Patents

Angiogenic factor and inhibitors thereof Download PDF

Info

Publication number
WO2004111088A3
WO2004111088A3 PCT/EP2004/006265 EP2004006265W WO2004111088A3 WO 2004111088 A3 WO2004111088 A3 WO 2004111088A3 EP 2004006265 W EP2004006265 W EP 2004006265W WO 2004111088 A3 WO2004111088 A3 WO 2004111088A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitors
angiogenic factor
sep
pharmaceutical compositions
relates
Prior art date
Application number
PCT/EP2004/006265
Other languages
French (fr)
Other versions
WO2004111088A2 (en
Inventor
Hendrik Gille
Beate Gawin
Rolf Schaefer
Stephan Hess
Christian Korherr
Irene Boche
Theresia Walter
Andreas Gnirke
Original Assignee
Xantos Biomedicine Ag
Hendrik Gille
Beate Gawin
Rolf Schaefer
Stephan Hess
Christian Korherr
Irene Boche
Theresia Walter
Andreas Gnirke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xantos Biomedicine Ag, Hendrik Gille, Beate Gawin, Rolf Schaefer, Stephan Hess, Christian Korherr, Irene Boche, Theresia Walter, Andreas Gnirke filed Critical Xantos Biomedicine Ag
Priority to EP04739768A priority Critical patent/EP1636258A2/en
Publication of WO2004111088A2 publication Critical patent/WO2004111088A2/en
Publication of WO2004111088A3 publication Critical patent/WO2004111088A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention relates to inhibitors of a novel angiogenic factor, SEP, and soluble derivatives thereof and to their use in pharmaceutical compositions.
PCT/EP2004/006265 2003-06-10 2004-06-09 Angiogenic factor and inhibitors thereof WO2004111088A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04739768A EP1636258A2 (en) 2003-06-10 2004-06-09 Angiogenic factor and inhibitors thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47747003P 2003-06-10 2003-06-10
US60/477,470 2003-06-10
US50338803P 2003-09-16 2003-09-16
US60/503,388 2003-09-16

Publications (2)

Publication Number Publication Date
WO2004111088A2 WO2004111088A2 (en) 2004-12-23
WO2004111088A3 true WO2004111088A3 (en) 2005-02-10

Family

ID=33555461

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2004/006265 WO2004111088A2 (en) 2003-06-10 2004-06-09 Angiogenic factor and inhibitors thereof
PCT/EP2004/006270 WO2004111085A1 (en) 2003-06-10 2004-06-09 Angiogenic factor and its medical use

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/006270 WO2004111085A1 (en) 2003-06-10 2004-06-09 Angiogenic factor and its medical use

Country Status (2)

Country Link
EP (1) EP1636258A2 (en)
WO (2) WO2004111088A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007054042A (en) * 2005-07-26 2007-03-08 Japan Science & Technology Agency Interferon-inducing molecule ips-1
EP1892528A1 (en) * 2006-08-25 2008-02-27 Institut Pasteur Use of a modulating agent that interacts with the pbd of plk proteins for modulating ifn induction
US11224665B2 (en) * 2016-10-05 2022-01-18 Duke University Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006552A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN
WO2002053737A1 (en) * 2000-12-28 2002-07-11 Asahi Kasei Kabushiki Kaisha Nf-kb activating gene
WO2003048202A2 (en) * 2001-12-03 2003-06-12 Asahi Kasei Pharma Corporation Nf-kappab activating genes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006552A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN
WO2002053737A1 (en) * 2000-12-28 2002-07-11 Asahi Kasei Kabushiki Kaisha Nf-kb activating gene
WO2003048202A2 (en) * 2001-12-03 2003-06-12 Asahi Kasei Pharma Corporation Nf-kappab activating genes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 30 January 2003 (2003-01-30), STRAUSBERG RL ET AL.: "Homo sapiens KIAA1271 protein, mRNA (cDNA clone MGC:50830 IMAGE:5751684), complete cds.", XP002297873, Database accession no. BC0044952 *
DATABASE EMBL EBI; 4 January 2002 (2002-01-04), STRAUSBERG RL ET AL.: "Mus musculus RIKEN cDNA D430028G21 gene, mRNA (cDNA clone MGC:25836 IMAGE:4190175), complete cds.", XP002297872, Database accession no. BC020006 *
MATSUDA AKIO ET AL: "Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.", ONCOGENE. 22 MAY 2003, vol. 22, no. 21, 22 May 2003 (2003-05-22), pages 3307 - 3318, XP002297871, ISSN: 0950-9232 *
THOMPSON J D: "Applications of antisense and siRNAs during preclinical drug development", DRUG DISCOVERY TODAY, ELSEVIER SCIENCE LTD, GB, vol. 7, no. 17, 1 September 2002 (2002-09-01), pages 912 - 917, XP002236964, ISSN: 1359-6446 *

Also Published As

Publication number Publication date
WO2004111088A2 (en) 2004-12-23
WO2004111085A1 (en) 2004-12-23
EP1636258A2 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
IL169469A (en) Folic acid derivatives containing disulfide linkers, pharmaceutical compositions comprising them and uses thereof
HUP0600057A2 (en) Glutaminyl based dpiv inhibitors, pharmaceutical compositions comprising thereof and their use
HUP0400194A3 (en) Imidazolidindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
EP2260835A3 (en) Composition for proteasome inhibition
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
AU2003293649A1 (en) Novel xanthine derivatives, the production and the use thereof in the form of drugs
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
EP2415760A3 (en) CCR-9 antagonists
IL220480A0 (en) 1-benzyl-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors , preparation method thereof, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
HK1089167A1 (en) 2-pyridone derivatives as netrophil elastase inhibitors and their use 2-
HUP0400193A3 (en) Imidazolindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
IL177496A0 (en) Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
ZA200702596B (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
AU2002228317A1 (en) Benz-1,3-azole derivatives and their uses as heparanase inhibitors
WO2007027314A3 (en) Anti-inflammatory compositions and methods of use
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
AU2003269421A1 (en) Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
HK1090356A1 (en) 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
HUP0400156A3 (en) Pyrrolidine derivatives as factor xa inhibitors, their preparation and pharmaceutical compositions containing them
WO2004112771A8 (en) Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
HUP0400438A3 (en) Broadspectrum 2-amino-benzoxazole-6-sulfonamides, their use as hiv protease inhibitor and pharmaceutical compositions containing them
WO2003074006A3 (en) Compositions and methods for preventing sporadic neoplasia in colon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004739768

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004739768

Country of ref document: EP

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWW Wipo information: withdrawn in national office

Ref document number: 2004739768

Country of ref document: EP